Clinical Report: Experience with Surgical Management of Giant Pituitary Adenomas
Overview
This report details the surgical management outcomes of 289 patients with giant pituitary adenomas at a single institution over 40 years. Key findings include the effectiveness of surgical approaches and the associated complication rates, emphasizing the importance of surgical strategy in managing these complex tumors.
Background
Giant pituitary adenomas, defined as tumors measuring ≥40 mm, pose significant challenges for neurosurgeons due to their size and potential invasiveness. These tumors can lead to serious complications, including hormonal imbalances and visual disturbances, necessitating effective surgical intervention. Understanding the outcomes of surgical management is crucial for optimizing treatment strategies and improving patient care.
Data Highlights
{'Gross-Total Resection Rate': 'Specify the percentage or rate.', 'Complication Rate': 'Specify the percentage or rate.'}
Key Findings
{'Complications': 'Provide detailed percentages and types of complications.'}
Clinical Implications
{'Multimodal treatment strategies': 'Include specific examples and their outcomes.'}
Conclusion
This extensive institutional experience highlights the complexities of managing giant pituitary adenomas and the importance of individualized surgical strategies to improve patient outcomes.
Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.
For years, chronic stroke patients heard familiar feedback regarding their ability to regain strength and mobility after ischemic strokes caused upper-extremity deficits.
